Committee Connection
  • In the Age of Novel Treatments for Chronic Lymphocytic Leukemia, Does Traditional FCR Chemotherapy Still Have a Place?

    24 Feb 2015 06:36 PM

    Introduction  Leo I. Gordon, MDRobert H. Lurie Comprehensive Cancer Center of Northwestern UniversityThere have been significant advances in our understanding of the biology of the B-cell malignancies over the past several years. These advances have enhanced our treatment options and have resulted in improved outcomes for patients with chronic lymphocytic leukemia (CLL) and other B-cell malignancies. In addition,... Read more

  • Perspectives on Use of Dietary Supplements and/or Vitamins in Cancer Prevention and Care

    14 Dec 2014 04:28 PM

    Introduction  Carolyn M. Matthews, MD Texas Tech Health Sciences Center and Baylor University Medical CenterAs you can surmise from the articles by Dr. Mark Moyad and Dr. L. Michael Glodé, one thing we can say with certainty is that dietary supplements are mired in controversy. Dogmatic statements for and against supplements abound in the medical literature; however, the evidence to support or discourage their use is not as clean... Read more

  • Induction Chemotherapy for Patients with Locally Advanced Head and Neck Cancer: To Induce or Not To Induce?

    24 Oct 2014 10:49 AM

    Introduction   Barbara Burtness, MDYale University School of MedicineThe role of induction chemotherapy in managing locally advanced head and neck cancer has been under exploration—and under debate—for three decades. The rationale for increasing exposure to systemic therapy has been expounded, and hints have been extrapolated from meta-analysis, or from trials comparing various induction regimens with each other, but not with... Read more

  • Robot-Assisted versus Open Radical Prostatectomy: Costs and Benefits

    26 Aug 2014 01:21 PM

    Introduction    By L. Michael Glodé, MD, FACP, FASCO University of Colorado Cancer Center The following articles by Dr. Quoc-Dien Trinh and Dr. Joel Nelson nicely review the current status of prostate cancer surgery and provide a framework within which one can discuss the approaches to definitive surgical ablation of the prostate. Although cost considerations should have been a part of the equation before dissemination of... Read more

  • Best Indications for PET/CT versus Contrast-Enhanced CT

    19 Jun 2014 02:37 PM

    Introduction   By Al B. Benson III, MD, FACP, FASCO Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University There is little question that advances in imaging technology have revolutionized cancer medicine, greatly enhancing precision in screening, diagnosis and staging, treatment, and surveillance. Functional imaging has the potential to refine staging accuracy and to provide a biologic... Read more

  • Cost of Cancer Care: A Crucial Physician-Patient Conversation

    22 Apr 2014 01:20 PM

    Introduction  Al B. Benson III,MD, FACP, FASCO By Al B. Benson III, MD, FACP, FASCOFeinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern UniversityCancer care costs and value are terms intertwined in the lexicon of the oncology discussion that has become the focal point of cancer care delivery over the past few years. Increasingly, clinicians and advocates alike... Read more